Health
Economic burden of acute myeloid leukemia treatment | JBM – Dove Medical Press
What does the economic burden of acute myeloid leukemia treatment look like for the next decade? An analysis of key findings, challenges and recommendations
AML: A Rare and Costly Cancer
Acute myeloid leukemia (AML) arises in the bone marrow from the abnormal clonal expansion of myeloid blood cell precursors. Leukemic blast cells are found in the circulating blood as well as in the bone marrow, where they disrupt normal blood cell production, leading to myelosuppression.1 Consequences of AML include anemia, with weakness and pallor, thrombocytopenia, resulting in bleeding, and leukopenia, leading to fever and infection.
AML, which accounts for about…
-
General23 hours agoTaylor Swift breaks Adele’s record for most album sales in first week
-
Noosa News24 hours agoMan charged with murder after alleged assault leaves 40-year-old dead in Hervey Bay
-
Noosa News24 hours agoQueensland Police Pipes and Drums to perform with World-Renowned Royal Edinburgh Military Tattoo
-
Noosa News22 hours agoWoman charged with Mark Akers’s murder after body found on roadside